Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-02-17

Clinical Trial Update: A Study Evaluating FT-SW in Unilateral Breast Cancer-Related Lymphedema Patients [NA]

View source ↗

Summary

Clinical trial for FT-SW in unilateral breast cancer-related lymphedema was terminated; results posted previously.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • FT-SW

Snippet

Sponsor: Tactile Medical | Conditions: Breast Cancer Related Lymphedema | NA | Status: TERMINATED | Results posted: 2021-02-17